PubMed=23106381; DOI=10.1089/scd.2012.0365
Mikkola M., Toivonen S., Tamminen K., Alfthan K., Tuuri T., Satomaa T., Natunen J., Saarinen J., Tiittanen M., Lampinen M., Valmu L., Partanen J., Otonkoski T.
Lectin from Erythrina cristagalli supports undifferentiated growth and differentiation of human pluripotent stem cells.
Stem Cells Dev. 22:707-716(2013)

PubMed=24098444; DOI=10.1371/journal.pone.0076205
Vuoristo S., Toivonen S., Weltner J., Mikkola M., Ustinov J., Trokovic R., Palgi J., Lund R.J., Tuuri T., Otonkoski T.
A novel feeder-free culture system for human pluripotent stem cell culture and induced pluripotent stem cell derivation.
PLoS ONE 8:E76205-E76205(2013)

PubMed=27411166; DOI=10.1002/dneu.22419
Achuta V.S., Grym H., Putkonen N., Louhivuori V., Karkkainen V., Koistinaho J., Roybon L., Castren M.L.
Metabotropic glutamate receptor 5 responses dictate differentiation of neural progenitors to NMDA-responsive cells in fragile X syndrome.
Dev. Neurobiol. 77:438-453(2017)

PubMed=29339535; DOI=10.1126/scisignal.aan8784
Achuta V.S., Moykkynen T., Peteri U.-K., Turconi G., Rivera C., Keinanen K., Castren M.L.
Functional changes of AMPA responses in human induced pluripotent stem cell-derived neural progenitors in fragile X syndrome.
Sci. Signal. 11:eaan8784.1-eaan8784.11(2018)

PubMed=30503263; DOI=10.1016/j.stemcr.2018.11.003
Danesi C., Achuta V.S., Corcoran P., Peteri U.-K., Turconi G., Matsui N., Albayrak I., Rezov V., Isaksson A., Castren M.L.
Increased calcium influx through L-type calcium channels in human and mouse neural progenitors lacking fragile X mental retardation protein.
Stem Cell Reports 11:1449-1461(2018)

PubMed=35677646; DOI=10.1016/j.isci.2022.104459
Narva E., Taskinen M.E., Lilla S., Isomursu A., Pietila M., Weltner J., Isola J., Sihto H., Joensuu H., Zanivan S., Norman J., Ivaska J.
MASTL is enriched in cancerous and pluripotent stem cells and influences OCT1/OCT4 levels.
IScience 25:104459.1-104459.21(2022)